RESUMO
To our knowledge, there is no study on the relationship between molecular spectral features and nutrient availability in chickpeas. The purpose of this study was to reveal molecular structure spectral profiles among cool-season adapted CDC chickpea varieties and detect the molecular structure changes induced by thermal processing methods using vibrational Fourier-transform infrared (FTIR) spectroscopy. Three varieties of chickpea samples (CDC Alma, Cory, Frontier) were finely ground using a 0.12 mm screen. Spectral analyses were conducted using a JASCO FTIR-4200 spectroscope with Spectra Manager II software in the mid-infrared region from ca. 4000−800 cm−1 with a 4 cm−1 resolution. Data were analyzed using the "Mixed" procedure of SAS 9.4. Multiple regression was performed with PROC REG analysis for variable selection. Results showed that amide I area was higher (p = 0.038) in CDC Frontier than CDC Cory (30.85 vs. 24.64 AU). Amide I peak height (p = 0.028) was also higher in CDC Frontier and CDC Alma (0.45 AU in both) than CDC Cory (0.36 AU). Cellulosic compound (CEC) to total CHO (TCHO) area ratio was higher in CDC Frontier (0.05 AU) than the other two varieties (0.14 AU in both). As to thermal treatment impact, the results showed that total amide area was higher (p = 0.013) with autoclave and microwave heating (47.38 and 45.19 AU, respectively) than dry heating (33.06 AU). The CEC area was also higher (p < 0.001) for autoclave and microwave heating (3.74 and 3.61 AU, respectively) than dry heating (2.20 AU). Moreover, the ratio of amide I to II height was higher (p = 0.022) with microwave heating than dry heating (1.44 vs. 1.16 AU, respectively). Relationship analysis showed that the effective degraded crude protein (EDCP) and bypass dry matter (% BDM) were associated with STCHO peaks and CEC height (p < 0.05, R2 = 0.68). Also, feed milk value (FMVDVE) was associated with STC1, STC_A, and CEC_A (p < 0.05, R2 = 0.85). In conclusion, vibrational molecular spectroscopy mid-infrared FTIR was able to reveal different molecular spectral characteristics among the cool-season adapted CDC chickpea varieties and detect molecular structure changes induced by thermal processing (dry heating, autoclaving, and microwave heating).
RESUMO
Throughout the COVID-19 pandemic, thousands of temporary ICUs have been established worldwide. The outcomes and management of mechanically ventilated patients in these areas remain unknown. OBJECTIVES: To investigate mortality and management of mechanically ventilated patients in temporary ICUs. DESIGN SETTING AND PARTICIPANTS: Observational cohort study in a single-institution academic center. We included all adult patients with severe COVID-19 hospitalized in temporary and conventional ICUs for invasive mechanical ventilation due to acute respiratory distress syndrome from March 23, 2020, to April 5, 2021. MAIN OUTCOMES AND MEASURES: To determine if management in temporary ICUs increased 30-day in-hospital mortality compared with conventional ICUs. Ventilator-free days, ICU-free days (both at 28 d), hospital length of stay, and ICU readmission were also assessed. RESULTS: We included 776 patients (326 conventional and 450 temporary ICUs). Thirty-day in-hospital unadjusted mortality (28.8% conventional vs 36.0% temporary, log-rank test p = 0.023) was higher in temporary ICUs. After controlling for potential confounders, hospitalization in temporary ICUs was an independent risk factor associated with mortality (hazard ratio, 1.4; CI, 1.06-1.83; p = 0.016).There were no differences in ICU-free days at 28 days (6; IQR, 0-16 vs 2; IQR, 0-15; p = 0.5) or ventilator-free days at 28 days (8; IQR, 0-16 vs 5; IQR, 0-15; p = 0.6). We observed higher reintubation (18% vs 12%; p = 0.029) and readmission (5% vs 1.6%; p = 0.004) rates in conventional ICUs despite higher use of postextubation noninvasive mechanical ventilation (13% vs 8%; p = 0.025). Use of lung-protective ventilation (87% vs 85%; p = 0.5), prone positioning (76% vs 79%; p = 0.4), neuromuscular blockade (96% vs 98%; p = 0.4), and COVID-19 pharmacologic treatment was similar. CONCLUSIONS AND RELEVANCE: We observed a higher 30-day in-hospital mortality in temporary ICUs. Although both areas had high adherence to evidence-based management, hospitalization in temporary ICUs was an independent risk factor associated with mortality.
RESUMO
BACKGROUND: Abdominal pain is a common complaint in children and its differential diagnosis includes inflammatory bowel disease (IBD). The aim of the study was to assess the diagnostic accuracy of scintigraphy with 99mTechnetium Hexamethylpropyleneamine Oxime (99mTc-HMPAO) labeled leukocytes in children with suspected IBD. MATERIAL AND METHODS: Eighty-five children (age 12.4 ± 4.3 years, 47% boys) with suspected IBD based on clinical presentation, laboratory and ultrasound findings underwent scintigraphy with 99mTc-HMPAO labeled leukocytes. Abdominal scintigrams were acquired 40 min and 90 min post injection, and whole body scintigrams at 180 min. Scintigraphy was evaluated by two specialists in nuclear medicine. The results were compared with the final diagnosis established by endoscopy, histology, other imaging methods, and follow-up evaluated by an expert in pediatric gastroenterology. RESULTS: Scintigraphy results corresponded with the final diagnosis in 78 (91%) patients resulting in a sensitivity of 89% (95%CI 72 to 98%), specificity of 91% (95% CI 82 to 98%), and accuracy of 91% (95% CI 83 to 96%). The interobserver agreement was 0.82 (95% CI 0.75 to 0.88) and the radiation dose estimate was 4.2 ± 1.5 mSv. In 28 children (25 positives and 3 negatives on scintigraphy), the diagnosis of IBD was established by endoscopy, histology, MR enterography, or fluoroscopy. Five positive findings on scintigraphy were not confirmed by other methods or during follow-up. CONCLUSION: Scintigraphy with 99mTc-HMPAO labeled leukocytes in children with suspected IBD has high accuracy and offers a non-invasive option for detecting the presence of gastrointestinal inflammation. Scintigraphy is a powerful non-invasive decision-making tool in the management of suspected IBD that may spare a greater proportion of children of more invasive and demanding examinations.